tradingkey.logo

Catalyst Pharmaceuticals Inc

CPRX

21.395USD

+0.275+1.30%
交易中 美东报价延迟15分钟
2.61B总市值
13.22市盈率 TTM

Catalyst Pharmaceuticals Inc

21.395

+0.275+1.30%
关于 Catalyst Pharmaceuticals Inc 公司
Catalyst Pharmaceuticals, Inc. 是一家商业阶段的生物制药公司。该公司专注于开发和商业化用于治疗罕见和难治疾病的一流药物。其旗舰商业产品是 FIRDAPSE(氨苯吡啶)片剂 10 毫克 (mg),获准用于治疗成人和 6 至 17 岁儿童的 Lambert-Eaton 肌无力综合征 (LEMS)。该公司还将 FYCOMPA(吡仑帕奈)CIII 作为处方药进行营销,可单独使用或与其他药物一起使用,用于治疗 4 岁及以上癫痫患者的局灶性发作(伴或不伴继发性全身性癫痫),以及与其他药物一起使用,用于治疗 12 岁及以上癫痫患者的原发性全身性强直阵挛性癫痫。其产品组合还包括 AGAMREE(vamorolone),一种用于治疗杜氏肌营养不良症 (DMD) 的 40 mg/ml 口服混悬液。 vamorolone 是一种用于治疗 DMD 患者的皮质类固醇药物。
公司简介
公司代码CPRX
公司名称Catalyst Pharmaceuticals Inc
上市日期Nov 08, 2006
CEOMr. Richard J. (Rich) Daly
员工数量181
证券类型Ordinary Share
年结日Nov 08
公司地址355 Alhambra Circle
城市CORAL GABLES
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编33134
电话13055292522
网址https://catalystpharma.com/
公司代码CPRX
上市日期Nov 08, 2006
CEOMr. Richard J. (Rich) Daly
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Patrick James Mcenany
Mr. Patrick James Mcenany
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
4.28M
-4.46%
Dr. Steven R. Miller, Ph.D.
Dr. Steven R. Miller, Ph.D.
Executive Vice President, Chief Operating Officer, and Chief Scientific Officer
Executive Vice President, Chief Operating Officer, and Chief Scientific Officer
949.66K
--
Mr. Donald A. Denkhaus
Mr. Donald A. Denkhaus
Independent Director
Independent Director
495.08K
--
Dr. David S. Tierney, M.D.
Dr. David S. Tierney, M.D.
Independent Director
Independent Director
355.62K
--
Mr. Richard J. (Rich) Daly
Mr. Richard J. (Rich) Daly
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
199.76K
-25.95%
Mr. Brian D. Elsbernd, J.D.
Mr. Brian D. Elsbernd, J.D.
Chief Compliance Officer, Chief Legal Officer
Chief Compliance Officer, Chief Legal Officer
188.56K
--
Dr. Gary Ingenito, M.D., Ph.D.
Dr. Gary Ingenito, M.D., Ph.D.
Chief Medical Officer and Regulatory Officer
Chief Medical Officer and Regulatory Officer
68.87K
--
Dr. Preethi Sundaram, Ph.D.
Dr. Preethi Sundaram, Ph.D.
Chief Strategy Officer
Chief Strategy Officer
41.08K
-8.72%
Ms. Molly Harper
Ms. Molly Harper
Lead Independent Director
Lead Independent Director
6.75K
--
Ms. Tamar Thompson
Ms. Tamar Thompson
Independent Director
Independent Director
1.41K
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Patrick James Mcenany
Mr. Patrick James Mcenany
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
4.28M
-4.46%
Dr. Steven R. Miller, Ph.D.
Dr. Steven R. Miller, Ph.D.
Executive Vice President, Chief Operating Officer, and Chief Scientific Officer
Executive Vice President, Chief Operating Officer, and Chief Scientific Officer
949.66K
--
Mr. Donald A. Denkhaus
Mr. Donald A. Denkhaus
Independent Director
Independent Director
495.08K
--
Dr. David S. Tierney, M.D.
Dr. David S. Tierney, M.D.
Independent Director
Independent Director
355.62K
--
Mr. Richard J. (Rich) Daly
Mr. Richard J. (Rich) Daly
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
199.76K
-25.95%
Mr. Brian D. Elsbernd, J.D.
Mr. Brian D. Elsbernd, J.D.
Chief Compliance Officer, Chief Legal Officer
Chief Compliance Officer, Chief Legal Officer
188.56K
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月16日 周五
更新时间: 5月16日 周五
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.46%
The Vanguard Group, Inc.
6.95%
State Street Global Advisors (US)
4.53%
McEnany (Patrick James)
3.51%
Deerfield Management Company, L.P.
2.81%
Other
68.75%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.46%
The Vanguard Group, Inc.
6.95%
State Street Global Advisors (US)
4.53%
McEnany (Patrick James)
3.51%
Deerfield Management Company, L.P.
2.81%
Other
68.75%
股东类型
持股股东
占比
Investment Advisor
43.94%
Investment Advisor/Hedge Fund
24.40%
Hedge Fund
8.56%
Individual Investor
6.05%
Research Firm
4.41%
Pension Fund
1.27%
Bank and Trust
0.44%
Family Office
0.17%
Sovereign Wealth Fund
0.10%
Other
10.67%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
675
109.00M
89.36%
-4.26M
2025Q1
693
109.47M
89.76%
-3.79M
2024Q4
658
108.09M
89.06%
-2.57M
2024Q3
628
104.82M
88.36%
-8.18M
2024Q2
597
106.41M
90.13%
-15.99M
2024Q1
590
105.68M
89.66%
-4.79M
2023Q4
569
93.52M
87.71%
-15.08M
2023Q3
548
90.12M
84.55%
-19.61M
2023Q2
542
91.66M
86.51%
-22.59M
2023Q1
518
97.83M
92.70%
-11.38M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
16.42M
13.46%
-409.06K
-2.43%
Mar 31, 2025
The Vanguard Group, Inc.
8.47M
6.95%
+64.49K
+0.77%
Mar 31, 2025
State Street Global Advisors (US)
5.53M
4.53%
-266.12K
-4.59%
Mar 31, 2025
McEnany (Patrick James)
4.28M
3.51%
-200.00K
-4.46%
Jun 09, 2025
Deerfield Management Company, L.P.
3.42M
2.81%
+289.14K
+9.23%
Mar 31, 2025
Renaissance Technologies LLC
2.96M
2.42%
+250.20K
+9.25%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.77M
2.27%
+100.08K
+3.75%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.19M
1.79%
-825.61K
-27.40%
Mar 31, 2025
Fundsmith LLP
2.15M
1.76%
+2.15M
--
Mar 31, 2025
Goldman Sachs & Company, Inc.
1.77M
1.45%
+371.01K
+26.53%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Neuroscience and Healthcare ETF
3.69%
Tema Neuroscience and Mental Health ETF
2.92%
Invesco Biotechnology & Genome ETF
2.32%
Invesco S&P SmallCap 600 GARP ETF
2.01%
Invesco S&P SmallCap Health Care ETF
1.78%
AAM Sawgrass US Small Cap Quality Growth ETF
1.65%
Invesco Dorsey Wright Healthcare Momentum ETF
1.64%
Pacer US Small Cap Cash Cows Growth Leaders ETF
1.56%
Janus Henderson Small Cap Growth Alpha ETF
1.52%
Janus Henderson Small/Mid Cap Growth Alpha ETF
1.44%
查看更多
iShares Neuroscience and Healthcare ETF
占比3.69%
Tema Neuroscience and Mental Health ETF
占比2.92%
Invesco Biotechnology & Genome ETF
占比2.32%
Invesco S&P SmallCap 600 GARP ETF
占比2.01%
Invesco S&P SmallCap Health Care ETF
占比1.78%
AAM Sawgrass US Small Cap Quality Growth ETF
占比1.65%
Invesco Dorsey Wright Healthcare Momentum ETF
占比1.64%
Pacer US Small Cap Cash Cows Growth Leaders ETF
占比1.56%
Janus Henderson Small Cap Growth Alpha ETF
占比1.52%
Janus Henderson Small/Mid Cap Growth Alpha ETF
占比1.44%
分红派息
近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI